pregnanolone
Selected indexed studies
- Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression. (Annu Rev Med, 2025) [PMID:39527720]
- Endogenous neurosteroids pregnanolone and pregnanolone sulfate potentiate presynaptic glutamate release through distinct mechanisms. (Br J Pharmacol, 2021) [PMID:33988248]
- Ganaxolone. (Am J Health Syst Pharm, 2022) [PMID:36099427]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Transformative Therapies for Depression: Postpartum Depression, Major Depressive Disorder, and Treatment-Resistant Depression. (2025) pubmed
- Zuranolone: First Approval. (2023) pubmed
- Ganaxolone: First Approval. (2022) pubmed
- Ganaxolone. (2022) pubmed
- Endogenous neurosteroids pregnanolone and pregnanolone sulfate potentiate presynaptic glutamate release through distinct mechanisms. (2021) pubmed
- Effects of Pregnanolone Glutamate and Its Metabolites on GABA(A) and NMDA Receptors and Zebrafish Behavior. (2023) pubmed
- Pregnanolone sulfate promotes desensitization of activated NMDA receptors. (2009) pubmed
- Neuroactive pregnanolone isomers during pregnancy. (2005) pubmed
- Endocrine response to pregnanolone. (1999) pubmed
- Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study. (2021) pubmed